These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 16740714
1. Role of SRC kinases in Neu-induced tumorigenesis: challenging the paradigm using Csk homologous kinase transgenic mice. Kaminski R, Zagozdzon R, Fu Y, Mroz P, Fu W, Seng S, Avraham S, Avraham HK. Cancer Res; 2006 Jun 01; 66(11):5757-62. PubMed ID: 16740714 [Abstract] [Full Text] [Related]
2. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK, Muller WJ. Oncogene; 1995 Nov 02; 11(9):1801-10. PubMed ID: 7478608 [Abstract] [Full Text] [Related]
3. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P. Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418 [Abstract] [Full Text] [Related]
4. Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis. Berman-Golan D, Granot-Attas S, Elson A. Cancer Metastasis Rev; 2008 Jun 01; 27(2):193-203. PubMed ID: 18231724 [Abstract] [Full Text] [Related]
5. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP. Cancer Res; 2005 Nov 15; 65(22):10174-8. PubMed ID: 16288002 [Abstract] [Full Text] [Related]
6. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM. Cancer Res; 1998 Dec 01; 58(23):5500-6. PubMed ID: 9850086 [Abstract] [Full Text] [Related]
8. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Berman-Golan D, Elson A. Oncogene; 2007 Oct 25; 26(49):7028-37. PubMed ID: 17486066 [Abstract] [Full Text] [Related]
9. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ. Cancer Res; 2002 Oct 01; 62(19):5405-7. PubMed ID: 12359744 [Abstract] [Full Text] [Related]
11. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM, Welsh J. Carcinogenesis; 2004 Dec 01; 25(12):2361-72. PubMed ID: 15333467 [Abstract] [Full Text] [Related]
12. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL. Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408 [Abstract] [Full Text] [Related]
13. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling. Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD. Mol Cancer Res; 2009 Nov 20; 7(11):1882-92. PubMed ID: 19861407 [Abstract] [Full Text] [Related]
14. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer. Gardner HP, Ha SI, Reynolds C, Chodosh LA. Cancer Res; 2000 Oct 01; 60(19):5571-7. PubMed ID: 11034105 [Abstract] [Full Text] [Related]
15. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS. Exp Mol Pathol; 2001 Jun 01; 70(3):183-93. PubMed ID: 11417997 [Abstract] [Full Text] [Related]
16. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW. Cancer Res; 1993 May 15; 53(10 Suppl):2272-8. PubMed ID: 8097963 [Abstract] [Full Text] [Related]
17. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P. Gene Ther; 1998 Mar 15; 5(3):388-93. PubMed ID: 9614559 [Abstract] [Full Text] [Related]
18. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG. Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676 [Abstract] [Full Text] [Related]
19. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC, Springs AE, Chen WY. Int J Oncol; 2009 Feb 15; 34(2):517-28. PubMed ID: 19148488 [Abstract] [Full Text] [Related]
20. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA. Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]